Axsome Therapeutics, Inc. (AXSM)

Seite 1 von 1
neuester Beitrag: 25.04.21 00:07
eröffnet am: 30.10.17 10:15 von: Chalifmann3 Anzahl Beiträge: 3
neuester Beitrag: 25.04.21 00:07 von: Melaniebqaua Leser gesamt: 3707
davon Heute: 1
bewertet mit 0 Sternen

30.10.17 10:15

23601 Postings, 5987 Tage Chalifmann3Axsome Therapeutics, Inc. (AXSM)

Top Chance auf Blockbuster ,hm ??!!  

30.10.17 10:16

23601 Postings, 5987 Tage Chalifmann3hier

Axsome Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the management of central nervous system (CNS) disorders. The company’s product candidates include AXS-05 that is in Phase III trial for the treatment of treatment resistant depression and Alzheimer’s disease agitation; and AXS-02, which is in Phase III trial to treat complex regional pain syndrome, knee osteoarthritis related to bone marrow lesions, and chronic low back pain related to Modic changes. It is also developing AXS-06, a preclinical product candidate for CNS disorders, including chronic pain. The company was founded in 2012 and is based in New York, New York.


09.03.20 13:14

23601 Postings, 5987 Tage Chalifmann3hi

hi leute,schaut mal was ich hier ausgegraben hab,bin leider nicht dabei .......


   Antwort einfügen - nach oben